论文部分内容阅读
一项新的研究显示,在身体质量指数(BMI)相似的情况下,肥胖(体重过重)的人不太容易在癌症化疗中康复,其中一个可能的原因是因超重,而未获适量的化疔剂量。莱曼8月在《自然》杂志发表的一篇论文表示,在动物实验中,降低化疗剂量20%将导致癌症治愈率降低50%,并且促使肿瘤细胞产生耐药性。其它研究者也证明,降低化疗剂量使得存活率也降低。而使未使用适量的化疗剂量,会令癌症病患癌细胞扩散,再次面临化疗;如一位2011年在杜克大学治疗乳腺癌的患者体重285磅,因使用标准剂量,而扩散到十几个淋巴。
A new study shows that people with obesity (overweight) are less likely to recover from cancer chemotherapy when the body mass index (BMI) is similar, and one possible reason for this is overweight without the proper amount of Chemical 疔 dose. In a paper published in Nature in August, Lyman said that reducing the dose of chemotherapy by 20% in animal experiments will result in a 50% reduction in the cure rate of cancer and the promotion of tumor cell resistance. Other investigators have also shown that decreasing the dose of chemotherapy leads to a decrease in survival. So that the use of appropriate doses of chemotherapy will spread cancer patients’ cancer cells and once again face chemotherapy. For example, a patient who had breast cancer treatment at Duke University in 2011 weighed 285 pounds and spread to a dozen lymph.